 Thrombolytic therapy thrombolytic agents years past decade clinical use agents treatment acute myocardial infarction available agents use treatment myocardial infarction streptokinase urokinase tissue plasminogen activator anistreplase agents works unique fashion common end point therapy dissolution fibrin clot conversion plasminogen number measurable end points effectiveness agents treatment acute myocardial infarction mortality reperfusion patency ventricular function ventricular volumes quantitative creatine kinase isoenzyme analysis Secondary end points bleeding stroke recurrent ischemic events Numerous clinical studies effectiveness agents desired end points comparative studies several large-scale trials agents regard efficacy Newer regimens available thrombolytic agents new thrombolytic agents active investigation subject intense research next years lack consensus agent superior clear thrombolytic therapy acute myocardial infarction treatment choice